Research Projects & Grants


  • Sentinel lymph node working group data acquisition project, Role: Investigator, University of California, San Francisco, (03/2023 - 03/2024) Status: Approved

For Profit Organization

  • A Double-Blind, Randomized Study to Assess the Quality of Life and Cost of Disease in Patients with Herpes Zoster Treated with Famciclovir or Placebo, Role: Investigator, Smithkline Beecham, (06/1995 - 06/1996) Status: Completed
  • A multi-center, open registry of patients with psoriasis who are candidates for systemic therapy including biologics, Role: PI, Jansseen Biotech, Inc., (09/2020 - 09/2021) Status: Completed
  • A multi-center study to assess the impact of topical corticosteriods on the safety and efficacy of protopic (tacrolimus) ointment in the short-term treatment of atopic dermatitis and to assess protopic in the long-term management of atopic dermatitis, Role: PI, Fujisawa, (10/2005 - 10/2006) Status: Completed
  • A Phase IIIb, open-label, multicenter study to evaluate the safety of 1.0 mg/kg subcutaneously administered Efalizumab in adults with moderate to severe plaque psoriasis, including those who are receiving concomitant antipsoriatic therapies or have recently transitioned from systemic therapies, Role: PI, Genentech, Inc., Status: Completed
  • Open-label study to evaluate the use of imiquimod 5% topical cream for reducing postsurgical recurrence or persistence of Basal Cell Carcinoma following excision by Curettage, Role: Investigator, 3M Pharmaceuticals, (10/2005 - 10/2006) Status: Completed
  • A prospective observational study of patients receiving Dupixent for Atopic Dermatitis, Role: PI, Regeneron Pharmaceuticals, Inc., (03/2020) Status: Approved
  • A phase 3, open-label study of the safety, efficacy, and tolerability of apomorphine administered by continuous subcutaneous infusion in advanced Parkinson's disease patients with unsatisfactory control on available therapy, Role: Investigator, U.S. World Meds, (11/2021 - 11/2022) Status: Completed
  • A 6 month, randomized, multicenter, parallel-group, double-blind, vehicle-controlled study to evaluate the efficacy and safety of ASM 981 (primecrolimus) cream 1% BID vs standard of care in management of mild to severe atopic dermatitis in children 3 months to 11 years, Role: PI, Novartis Pharma AG, Status: Completed
  • A multi-center, epidemiology study to evaluate the potential for adverse health effects in fetuses and live-born infants following a woman's pregnancy, compared with a similar group of psoriatic women not exposed to tazarotene and compared with background levels in general population., Role: PI, Allergan Inc., (01/2006 - 01/2007) Status: Completed
  • A clinical study evaluating the safety and efficacy of Tazorac gel compared with Dovonex 0.005% ointment in the treatment of individuals with stable plaque psoriasis, Role: PI, Allergan Inc., Status: Completed
  • Tazorac (Tazarotene topical gel 0.1%) observation study in stable plaque psoriasis on up to 20% body surface, Role: PI, Allergan Inc., (09/1998 - 09/1999) Status: Completed


  • A Comparison Between Cryosurgery Alone, Cryosurgery Plus Interferon, and Interferon Alone in the Treatment and Long-Term Recurrence of Condyloma Acuminata, Role: PI, LLU Dept. of Medicine, Status: Completed